NPRJohnson & Johnson Vaccine Is 66% Effective In Preventing Moderate To Severe COVID-19Jan 29, 2021Scott HensleyBy Scott Hensleymore_vert
PR NewswireJohnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim ...Jan 29, 2021more_vert
ABC NewsJohnson & Johnson single-shot vaccine 85% effective against severe COVID-19 diseaseJan 29, 2021Sony SalzmanBy Sony Salzmanmore_vert
Yahoo! VoicesJohnson & Johnson COVID-19 vaccine is 66% effective in global trial, but 85% effective against severe disease ...Jan 29, 2021more_vert